Search

World Cancer Day, observed annually on 4 February, raises awareness about cancer, encourages its prevention, and mobilises action to address the global cancer epidemic.

A new era of research that promises to uncover novel information on the physiology of the human vagus nerve is unfolding right before our eyes.

'We work a lot with families, babies, pregnancy and young people, and our goal is to see them flourish or to do research that can move them towards that trajectory of flourishing and not just always surviving.'

When it comes to individual health and wellbeing, differences between sex and gender matter and the more consideration that we give to these differences, the more we can improve health outcomes for everyone.

The Procedures and requirements for meeting the 2011 NHMRC standard for clinical practice guidelines are designed to support guideline developers, including those seeking NHMRC approval, to ensure that guidelines are developed to the highest standard.

The Australian Code for the Responsible Conduct of Research, 2007 (the 2007 Code) guides institutions and researchers in responsible research practices and promotes research integrity. It assists institutions in developing their own employee codes of conduct and procedures for the investigation of allegations of research misconduct by providing a comprehensive framework of acceptable academic standards.

This Information Paper explores the potential link between water fluoridation and human health based. The 2016 NHMRC Evidence Evaluation shows that water fluoridation helps to reduce tooth decay in children and adults. There is no reliable evidence that water fluoridation at current Australian levels causes health problems.

Grant outcomes for the 2025 NHMRC grant application round will be provided incrementally throughout the year. The outcome datasets may include a small number of schemes for which applications closed in the previous year.

NHMRC has been investigating concerns about the impact of wind farms on human health since 2009, following concerns raised by the public.  This administrative report refers to the development of a related information paper, NHMRC Statement and evidence-based background documents.

The NHMRC Corporate Plan 2024-25 presents our strategy for building a healthy Australia, across the strategic themes (purposes) of investment, translation and integrity of health and medical research. The plan also includes our strategic and health priorities, as well as our key activities planned for 2024–25 and over the next few years. The plan describes the operating context in which we work and outlines our performance criteria and targets for the next 4 years.

Guideline impact Determining what measures to use are important, but equally important is to know how to use the data to tell a story.

This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2021–22. An accessible version of this document is available on the Transparency Portal.

The NHMRC Corporate Plan 2020-21 covers the four years to 2023-24. In line with legislated requirements, it identifies major health issues likely to arise, how NHMRC will deal with these issues (including the continuing impact of COVID-19) and our strategy for health and medical research. It also details the key activities NHMRC will undertake to achieve our purposes, and the operating context in which we work, comprising: environment, capability, risk oversight and management, and organisations NHMRC cooperates with to achieve our purposes.

The NHMRC Corporate Plan 2021–22 presents our national strategy for health and medical research aligned with our three strategic purposes of investment, translation and integrity. The plan includes updated strategic priorities and health priorities and outlines our planned key activities in 2021–22 and over the next four years. The plan also describes the operating context in which we work and our performance criteria and targets for the next four years.

These guidelines provide a framework in which medical research involving personal information obtained by Commonwealth agencies should be conducted, to ensure the information is protected.